EU Alzheimers Therapeutics and Diagnostics Market, Market Segmented by Drugs (Marketed Drugs, Pipeline Drugs), by Disease Stage (Late Stage: Severe Ad, Early/Middle Stage: Mild to Moderate Ad, Prodromal Stage) and by Diagnostics (Lumbar Puncture Test, Positron Emission Tomography, Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Other Diagnostics) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138265
- Pages: 200
-
Format:
Report Overview
The EU Alzheimers Therapeutics and Diagnostics Disease market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.59% during the forecast period
Alzheimers disease is a neurological condition in which the death of brain cells causes memory loss and cognitive decline. Alzheimer's diseaseis an irreversible, progressive braindisorder that slowly destroys memory, thinking skills and, eventually, the ability to carry out the simplest tasks
Market Drivers
The growth of the market is mainly driven by factors such as rising geriatric population, upsurge in healthcare spending and increasing government subsidy. In addition, growing healthcare cognizance and innovative diagnostic technologies are also stimulating the growth of the market. However, the stringent regulations and expiry of patented drugs may restrain the market growth
1. EU Alzheimers Therapeutics and Diagnostics Disease Market Overview.........
A. Market Size
2. Market Growth Drivers.........................................................................
A. Growing geriatric population
B. Increase in government subsidy and healthcare spending
3. EU Alzheimers Therapeutics and Diagnostics Disease Market Segmentation.
A. By Therapeutics
I. Marketed Drugs
II. Pipeline Drugs
B. By Disease Stage
I. Late Stage: Severe Ad
II. Early/Middle Stage: Mild to Moderate Ad
III. Prodromal Stage
C. By Diagnostics
I. Lumbar Puncture Test
II. Positron Emission Tomography
III. Electroencephalography
IV. Magnetic Resonance Imaging
V. Computed Tomography
VI. Other Diagnostics
4. EU Alzheimers Therapeutics and Diagnostics Disease Market Major Market Share............
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Allergan Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Eli Lilly Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Regulatory Framework
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities............
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
